Peptide startup gold rush continues as more & more vcs ok with publicly backing gray market.
FEEL PEPTIDES RAISES $3M SEED
Feel Peptides closed a $3M seed round led by Sugar Capital.
Most of the consumer peptide market still runs through compounding pharmacies, gray market online sellers, and wellness clinics with minimal transparency on sourcing or purity.
Feel is the brand layer when the FDA clarifies its restrictions on popular peptides, a regulatory reset that's been building since 2023 and has more political tailwind now.
Sugar Capital backed Grüns, sold to Unilever for $1.2B less than three years after launch.
Another peptide startup Protocole just raised a $6M seed led by Rare Capital last month.